Cart
sales@molnova.com
FEN1-IN-1
CAS No. 824983-91-7
FEN1-IN-1( LNT-1 )
Catalog No. M24814 CAS No. 824983-91-7
FEN1-IN-1 is an inhibitor of flap endonuclease 1 (FEN1). FEN1-IN-1 binds to the active site of FEN1. It partly achieves inhibition by the co-ordination of Mg2+ ions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFEN1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionFEN1-IN-1 is an inhibitor of flap endonuclease 1 (FEN1). FEN1-IN-1 binds to the active site of FEN1. It partly achieves inhibition by the co-ordination of Mg2+ ions.
-
DescriptionFEN1-IN-1 is an inhibitor of flap endonuclease 1 (FEN1). FEN1-IN-1 binds to the active site of FEN1. It partly achieves inhibition by the co-ordination of Mg2+ ions.
-
In Vitro——
-
In Vivo——
-
SynonymsLNT-1
-
PathwayOthers
-
TargetOther Targets
-
Recptorflap endonuclease 1 (FEN1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number824983-91-7
-
Formula Weight332.33
-
Molecular FormulaC15H12N2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (752.26 mM; Need ultrasonic)
-
SMILESON(C(c(scc1)c1N1CC2Oc(cccc3)c3OC2)=O)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ward TA, et al. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes. PLoS One. 2017 Jun 19;12(6):e0179278.
molnova catalog
related products
-
Vitexia-glucoside
Vitexia-glucoside is a natural product isolated from Briza stricta.
-
Rabies Virus Glycopr...
Rabies Virus Glycoprotein (TFA) is a kind of by the Rabies Virus Glycoprotein 29 - amino acid derived cell penetrating peptides, it can pass the blood brain barrier (BBB) into the brain cells.
-
Isogambogenic acid
Isogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy.
